reports
Tanco Holdings Berhad: 1 director
A director at Tanco Holdings Berhad bought 2,331,100 shares at 1.141MYR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Ovintiv Inc: 3 directors
Three Directors at Ovintiv Inc sold/gave away/sold after exercising options 57,310 shares at between 0.000USD and 42.500USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by ...
Heineken® 0.0 x LÕK serve up the world’s first padel racket with a bui...
Heineken® 0.0 x LÕK serve up the world’s first padel racket with a built-in bottle opener Heineken® 0.0 and premium racket brand LÕK announce the first-ever padel racket with a built-in bottle opener and six-pack branded ballsThe launch adds to Heineken® 0.0's expanding presence in padel, adding to its new global partnerships with Playtomic and Premier Padel AMSTERDAM, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Heineken® 0.0 and LÕK today announce the Special Edition Heineken® 0.0 x LÕK collection, featuring a Special Heineken® 0.0 edition of the LÕK Jungle, the first-ever padel racket with a b...
Erste Ergebnisse aus BioNTechs und BMS’ globaler Phase-2-Studie mit bi...
Erste Ergebnisse aus BioNTechs und BMS’ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig zeigten ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem dreifach negativem Brustkrebs Zwischenergebnisse der globalen klinischen Phase-2-Studie bei lokal fortgeschrittenem/metastasiertem dreifach negativem Brustkrebs (triple-negative breast cancer, „TNBC“) zeigten eine ermutigende Anti-Tumor-Aktivität für Pumitamig (BNT327/BMS986545) in Kombination mit Chemotherapie bei Patientinnen und Patienten in der Erst- oder ZweitlinienbehandlungPumitamig in Kombination m...
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data fo...
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for investigational therapy pumitamig (BNT327/BMS986545) plus chemotherapy in first- and second-line patientsPumitamig plus chemotherapy achieved confirmed objective response rate (cORR) of 61.5%, unconfirmed ORR (uORR) of 71.8% and disease control rate (DCR) of 92.3% irrespec...
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourci...
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today released a year-end Letter from Chief Executive Officer Jody Aufrichtig, summarizing the Company’s 2025 achievements and outlining its strategic vision for 2026. In his year-end letter to shareholde...
Gencor Releases Fourth Quarter and Fiscal Year 2025 Results
Gencor Releases Fourth Quarter and Fiscal Year 2025 Results ORLANDO, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today net revenue for the fourth quarter ended September 30, 2025 of $18.8 million, down 10.0% from $20.9 million net revenue for the quarter ended September 30, 2024. Gross profit as a percentage of net revenue was 24.2% for the quarter ended September 30, 2025, compared to 25.6% for the quarter ended September 30, 2024. The lower gross profit margin in fiscal 2025 was due to reduced manufacturing ...
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melan...
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma Expert panel offers data-driven guidance for integrating DecisionDx-Melanoma into clinical decision-making for patients with melanoma FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent expert consensus paper titled “31-Gene Expression Profiling for Cutaneous Melanoma: An Expert Consensus...
TopBuild Hosting 2025 Investor Day on December 9, Providing Strategic ...
TopBuild Hosting 2025 Investor Day on December 9, Providing Strategic Outlook on Business DAYTONA BEACH, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp., (NYSE:BLD) a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building products to the construction industry in the United States and Canada, is hosting its Investor Day in New York City today, December 9, beginning at 8:00 a.m. ET. TopBuild’s President and CEO Robert Buck, CFO Rob Kuhns, and other members of the senior leadership team will present an in-depth overview o...
Skyharbour and JV Partner Orano Announce Extensive Exploration and Dri...
Skyharbour and JV Partner Orano Announce Extensive Exploration and Drilling Plans for 2026 at Preston Uranium Project Vancouver, BC, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: ) (OTCQX: ) (Frankfurt: ) (“Skyharbour” or the “Company”) is pleased to announce that its joint-venture partner, Orano Canada Inc. (“Orano”), is planning a substantial 2026 exploration and drilling program at the 49,635 hectare Preston Uranium Project (“Preston” or the “Property”) located in the western Athabasca Basin, Saskatchewan, Canada. The upcoming program will include an Airborne Grav...
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase...
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of all responses were MRD negative) at RP2D, 7.6 months median duration of composite Complete Remission across all patients, and a favorable safety profilePharmacodynami...
Aeluma Files New Patent That Enhances Intellectual Property for Large-...
Aeluma Files New Patent That Enhances Intellectual Property for Large-Scale High Performance Semiconductor Manufacturing Strengthens Aeluma’s Heterogeneous Integration Platform and Expands Intellectual Property Portfolio to 35 Issued and Pending Patents GOLETA, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today that it has filed a new patent application, expanding its intellectual property por...
Ollie’s Bargain Outlet Holdings, Inc. Announces Third Quarter Fiscal 2...
Ollie’s Bargain Outlet Holdings, Inc. Announces Third Quarter Fiscal 2025 Results Store Openings, Sales, and Earnings Ahead of Expectations Net Sales Increased 18.6% and Earnings Per Share Increased 29.3% Raising Fiscal 2025 Sales and Earnings Outlook HARRISBURG, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced financial results for the third quarter ended November 1, 2025. “Thanks to the extraordinary execution of our team, we delivered another strong performance in the third quarter. We opened a record number...
Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) D...
Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) based on preliminary clinical evidence, and offers benefits of FDA working closely with Senti Bio to provide guidance and advice on generating the data needed to support approval of the product in an efficient mannerSecond FDA designation for SENTI-202 this ye...
Safe Harbor Launches New Payroll Cashflow Solution and Announces Major...
Safe Harbor Launches New Payroll Cashflow Solution and Announces Major Banking Win with Canopy HR Payroll Boost improves operator liquidity and creates multiple new revenue opportunities for Safe Harbor DENVER, Dec. 09, 2025 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a provider of banking, lending, and financial services to the legal cannabis industry, announced that —one of the largest payroll-service providers in the cannabis sector—selected Safe Harbor to support nearly all of its cannabis payroll banking operations. The engagemen...
CRML Executes Term-Sheet for 50/50 Joint Venture With EU and NATO Memb...
CRML Executes Term-Sheet for 50/50 Joint Venture With EU and NATO Member, Romania, Creating a Fully Integrated Mine-to-Processing Supply Chain for Long-Term Security for the European Manufacturing & National Security Sectors NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp.” or the “Company”), a leading critical minerals mining company, today announced that it has executed the Term-Sheet for creating a 50%-50% joint venture (JV) between CRML and Fabrica de Prelucrare a Concentratelor de Uraniu S.R.L. (FPCU) of Romania, a state-owned e...
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance Introduces 2026 full year revenue guidance of $245 million to $285 million, an approximately 15% increase in core revenue growth over 2025, royalty revenue of $200 to $225 million, a 40% increase over 20251, and core adjusted earnings per diluted share of $8.00 to $9.002Increases 5-year royalty receipt outlook driven by Filspari, Ohtuvayre, and Zelsuvmi; expects to meet or exceed 23% compound annual growth rate$1 billion in deployable capital expected to drive long-term royalty revenue growth JUPITER, Fla., Dec. 09, 2025 (GLOBE ...
G-III Apparel Group, Ltd. Reports Third Quarter Fiscal 2026 Results an...
G-III Apparel Group, Ltd. Reports Third Quarter Fiscal 2026 Results and Updates Fiscal 2026 Outlook; Initiates First Ever Quarterly Dividend Program Net Income Per Diluted Share of $1.84 and Non-GAAP Net Income Per Diluted Share of $1.90 for the Third Quarter, Both Exceeding GuidanceNet Sales of $988.6 Million for the Third QuarterRaises GAAP and Non-GAAP Net Income Per Diluted Share GuidanceMaintains Strong Cash and Availability PositionIntroduces First Ever Quarterly Dividend of $0.10 Per Share NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NasdaqGS: GIII) (“G-I...
Aya Gold & Silver Reports High-Grade Silver Results at Zgounder
Aya Gold & Silver Reports High-Grade Silver Results at Zgounder MONTREAL, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce additional high-grade silver drill results from its at-depth drill exploration program at the Zgounder Silver Mine in the Kingdom of Morocco. Highlights (all intersections are in core lengths) Intersections in the open-pit area: Hole ZG-RC-25-478 intercepted 677 grams per tonne (“g/t”) silver (“Ag”) over 15.0 metres (“m”), including 2,138 g/t Ag over 3.0mHole DZG-SF-25-7...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.